Advertisement
The end of the second deadliest Ebola outbreak in history was officially marked Thursday by the Democratic Republic of Congo.

Congo Marks End of World’s Second Deadliest Ebola Outbreak

0
The outbreak began in August 2018 and resulted in 2,280 deaths
Among women of reproductive age with COVID-19

Risk for Hospitalization Up for Pregnant Women With COVID-19

0
Pregnant women with COVID-19 more likely to be admitted to ICU, receive mechanical ventilation
HIV testing occurs at less than 1 percent of physician office and emergency department visits and at less than 3 percent of community health center visits

CDC: HIV Testing Occurs at <1 Percent of Physician Visits

0
Tests performed at 2.65 percent of community health clinic visits, 0.55 percent of ED visits
The U.S. burden of skin and subcutaneous diseases is large but varies geographically

U.S. Burden of Skin and Subcutaneous Diseases Increasing

0
Increases seen across all 50 states, with geographic variation in percentage
Factors readily available in administrative data can predict five- and 10-year mortality in older adults with diabetes

Administrative Data Predict Mortality With Diabetes

0
Thirty-seven factors have good accuracy for predicting five- and 10-year mortality in older veterans
Triple therapy

Triple Inhaled Therapy Aids in Moderate-to-Very Severe COPD

0
Benefit seen for twice-daily triple inhaled therapy with glucocorticoid, glycopyrrolate, formoterol
The prevalence of metabolic syndrome among young adults in the United States is rising

Metabolic Syndrome Up in Young Adults in the United States

0
Significant increases between 2011 and 2016 also seen for women, Asians, and Hispanics
It is possible to predict the likelihood of testing positive for COVID-19

Model May Help Predict Risk for Testing Positive for COVID-19

0
Risk reduced with pneumococcal polysaccharide, flu vaccine; melatonin, paroxetine, or carvedilol use
Inhibition of sclerostin with romosozumab may increase cardiovascular risk

Inhibition of Sclerostin May Increase Cardiovascular Risk

0
SOST genetic variants linked to lower risk for fracture and osteoporosis but higher risk for MI, major CV AEs
Use of tocilizumab to target cytokine release syndrome seems beneficial for patients with COVID-19

Tocilizumab Shows Promise for Treatment of COVID-19

0
Tocilizumab improves oxygenation and inflammatory biomarkers, may improve survival in severe disease